Internal Medicine · Flushing, NY
NPI
1316124795
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
4160 Main St Unit 312
Flushing, NY, 11355
Phone (718) 865-8648
Medicare paid, 2024
$14K
200 services
Medicare patients, 2024
47
Average age 75
Drug cost, 2024
$5.9M
62,062 prescriptions
Company payments, 2025
$1,389
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Xiandong Shi was code 99213 (office e&m - established), 160 times for 44 patients. In total Xiandong Shi billed 200 services in 8 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 160 | 44 | $67.28 | $11K |
| 99212 Office E&M - Established | Office | 16 | 11 | $44.57 | $713 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 12 | 12 | $138.57 | $1,663 |
By year: 2022 $21K for 329 services; 2023 $17K for 261 services; 2024 $14K for 200 services.
Medicare prescription drug claims, 2024
In 2024, the drug Xiandong Shi prescribed most often to Medicare patients was Atorvastatin Calcium, with 4,135 prescriptions and refills. In total Xiandong Shi wrote 62,062 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 4,135 | 5,372 | 530 | $21K |
| Vascepa Icosapent Ethyl | 3,328 | 3,560 | 426 | $1.2M |
| Gabapentin Generic | 2,816 | 3,030 | 431 | $43K |
| Amlodipine Besylate Generic | 2,711 | 3,434 | 343 | $12K |
| Omeprazole Generic | 2,466 | 2,793 | 399 | $17K |
| Metformin Hcl Generic | 2,176 | 2,746 | 278 | $11K |
| Tamsulosin Hcl Generic | 1,827 | 2,172 | 228 | $12K |
| Meloxicam Generic | 1,739 | 1,829 | 331 | $6,448 |
| Finasteride Generic | 1,567 | 1,891 | 194 | $7,293 |
| Losartan Potassium Generic | 1,559 | 1,997 | 198 | $7,658 |
| Baclofen Generic | 1,497 | 1,529 | 243 | $15K |
| Montelukast Sodium Generic | 1,243 | 1,352 | 173 | $6,231 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 1,229 | 1,586 | 166 | $11K |
| Clobetasol Propionate Generic | 1,093 | 1,263 | 190 | $217K |
| Donepezil Hcl Generic | 1,039 | 1,150 | 129 | $5,551 |
Brand drugs: 8,543 claims; generic drugs: 51,843 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Xiandong Shi $1,389 ($1,389 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $401.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $401 |
| Amgen Inc. AMGN | 11 | $222 |
| Gilead Sciences, Inc. GILD | 8 | $175 |
| Axsome Therapeutics, Inc. AXSM | 2 | $154 |
| Novo Nordisk Inc NVO | 9 | $142 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $76.48 |
| Lilly USA, LLC LLY | 3 | $64.39 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $41.84 |
| Aimmune Therapeutics, Inc. | 1 | $29.94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.